The Use of the GlideScope Ranger in Pediatric Critical Care Transport
|ClinicalTrials.gov Identifier: NCT01054183|
Recruitment Status : Completed
First Posted : January 22, 2010
Results First Posted : February 5, 2015
Last Update Posted : February 23, 2015
|Condition or disease||Intervention/treatment||Phase|
|Respiratory Failure||Device: GlideScope Ranger Intubation Device: Direct Laryngoscopy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||22 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||The Use of the GlideScope Ranger in Pediatric Critical Care Transport|
|Study Start Date :||July 2010|
|Actual Primary Completion Date :||November 2011|
|Actual Study Completion Date :||December 2011|
Experimental: Intubation using GlideScope Ranger
The study site has two critical care transport teams per shift and will, at shift change, assign intubation team A to use the GlideScope Ranger for all intubations on that day.
Device: GlideScope Ranger Intubation
Intubation with GlideScope Ranger Video Laryngoscope
Active Comparator: intubation using direct laryngoscopy
The study site has two critical care transport teams per shift and will, at shift change, assign intubation team B. Team B will do intubations using direct laryngoscopy only that day.
Device: Direct Laryngoscopy
Intubations will be done with direct laryngoscopy.
- Percent of Participants With Successful 1st Intubation Attempt [ Time Frame: 30 days ]Percent of participants with successful 1st intubation attempt by group (GVL vs. DL)
- Overall Successful Intubation Rate: GlideScope Video Laryngoscopy (GVL) vs. Direct Laryngoscopy (DL). [ Time Frame: 30 days; no long-term outcome measures were included ]Overall successful intubation rate defined as all successful intubations (by type) divided by all attempts (by type).
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01054183
|United States, Ohio|
|Akron Children's Hospital|
|Akron, Ohio, United States, 44308|
|Principal Investigator:||Michael T Bigham, M.D.||Akron Children's Hospital|